PDCD1 and T-cell non-Hodgkin lymphoma: The relationship between ICIs and the development of T-cell lymphomas remains unclear; however, several case reports have described T-cell lymphomas emerging after PD-1 inhibitor therapy (Table 2) [5,11-18].